Cargando…
LINC00472 suppresses oral squamous cell carcinoma growth by targeting miR-455-3p/ELF3 axis
LINC00472 is reported to play a role in suppressing tumors in cancers such as lung cancer and hepatocellular carcinoma, among others. We made investigations into the effects of LINC00472 in oral squamous cell carcinoma (OSCC) progression to explore the underlying molecular mechanisms. By qRT-PCR, we...
Autores principales: | Liu, Xiu, Ma, Xinrong, Li, Hongyu, Wang, Yu, Mao, Minghui, Liang, Chao, Hu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805930/ https://www.ncbi.nlm.nih.gov/pubmed/35258410 http://dx.doi.org/10.1080/21655979.2021.2018092 |
Ejemplares similares
-
LINC00472 suppressed by ZEB1 regulates the miR‐23a‐3p/FOXO3/BID axis to inhibit the progression of pancreatic cancer
por: Bi, Cong, et al.
Publicado: (2021) -
Long non-coding RNA LINC00472 inhibits oral squamous cell carcinoma via miR-4311/GNG7 axis
por: Zou, Chen, et al.
Publicado: (2022) -
Linc00472 suppresses proliferation and promotes apoptosis through elevating PDCD4 expression by sponging miR-196a in colorectal cancer
por: Ye, Yafei, et al.
Publicado: (2018) -
Down-regulation of LINC00472 promotes osteosarcoma tumorigenesis by reducing FOXO1 expressions via miR-300
por: Zhang, Jingwei, et al.
Publicado: (2020) -
Retraction: Linc00472 suppresses breast cancer progression and enhances doxorubicin sensitivity through regulation of miR-141 and programmed cell death 4
por: Fisher, Laura
Publicado: (2021)